Substance Use Disorder: Identification and Referral Part I

Substance Use Disorder: Identification and Referral Part I is organized by Pennsylvania Pharmacists Association (PPA).

Release Date: 7/25/2022
Expiration Date: 7/25/2025

Program Objectives:
At the completion of this activity, the participant will be able to:

• Differentiate observational studies from experimental studies
• Describe the biopsychosocial approach to health
• Explain the Adverse Childhood Experiences Study
• List risk and prognostic factors related to substance disorders
• Name factors that affect the distribution and metabolism of drugs of these substances
• Explain the steps of neurotransmission
• Describe the reward pathway of the brain and natural rewards
• Explain how neurotransmitters are altered by drugs of misused substances
• Define addiction, tolerance, dependence, and withdrawal
• Explain the role of tolerance in drug overdoses
• Describe addiction as a disease model
• Describe the relationship between stigma and barriers to the assessment of Substance Use Disorders
• Explain the general characteristics of Substance Use Disorders
• Explain the symptoms of Substance Use Disorders
• Explain the indicators of drug seeking behavior
• Describe why Pennsylvania and other states have adopted the Prescription Drug Monitoring Program (PDMP)
• Identify the main purposes of the PDMP
• Discuss the legal requirements for pharmacists and prescribers in relationship to the PDMP
• Review how prescribers, dispensers and designated assistants use the PDMP
• Describe the Screening, Brief Intervention, and Referral to Treatment (SBIRT) approach
• Review the use of evidence-based screening tools for substance use disorders
• Determine which screening tool to use given a patient case and interpret screening results
• Discuss barriers and solutions to implementing screening for substance use disorders
• Explain the purpose of an intervention
• Identify the types of interventions
• Provide an overview of each type of intervention
• Determine the type of intervention that is most appropriate for a given situation
• Define a warm hand-off
• Identify the role of members of the healthcare team, including patient navigators and other stakeholders, in the warm hand-off
• Discuss the step-wise process in conducting a warm hand-off in a health-system setting
• Discuss the step-wise process in conducting a warm hand-off in a community/outpatient setting
• Identify resources for the assessment and treatment of substance use disorders that can be used in the development of a protocol
• Describe how motivational interviewing (MI) can be used to effectively promote behavior change
• Review MI techniques and skills to utilize in behavior change interventions
• Observe a brief intervention using motivational interviewing (MI) techniques to elicit change talk
• List the main classifications of drugs of misused substances
• Give examples of drugs in each class
• Explain the schedule classification of drugs and give examples in each schedule
• Explain the mechanism of action of each class of drugs and how that is related to addiction
• List street names of the commonly used substances 
• Explain the difference between opiates and opioids
• Explain in your own words how addiction is a disease .